Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats
Marc Mejias, Ester Garcia‐Pras, Carolina Tiani, Rosa Miquel, Jaime Bosch, Mercedes Fernandez – 27 March 2009 – Portal hypertension, the most important complication in patients with cirrhosis of the liver, is a serious and life‐threatening disease for which there are few therapeutic options.